A10BB09 • gliclazide • Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas
Gliclazide is an antidiabetic medication from the sulfonylurea class, used to control blood sugar levels in patients with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, thereby helping to lower blood sugar levels.
It is recommended as part of a treatment plan that includes a balanced diet, regular physical activity, and blood sugar monitoring. Gliclazide is effective in preventing diabetes-related complications, such as damage to small blood vessels (retinopathy, nephropathy).
Side effects may include hypoglycemia (excessive drop in blood sugar), nausea, dizziness, or weight gain. It is important for patients to follow the prescribed dosage and watch for signs of hypoglycemia, such as shaking, sweating, or confusion.
Substance: gliclazide
Date of last drug list: 10-04-2026
Commercial code: W69999007
Concentration: 60mg
Pharmaceutical form: prolonged-release tablets
Quantity: 60
Product type: generic
Price: 34.31 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: MEDIS INTERNATIONAL A.S. - REPUBLICA CEHA
Holder: GEMAX PHARMA S.R.O. - REPUBLICA CEHA
Number: 14685/2022/07
Shelf life: 2 years